Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM.

Open source

DOI
10.1067/mjd.2000.106374
Published
2000-08-01
Container
J Am Acad Dermatol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1067/mjd.2000.106374,
  title = {Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?},
  author = {Krueger GG and  Feldman SR and  Camisa C and  Duvic M and  Elder JT and  Gottlieb AB and  Koo J and  Krueger JG and  Lebwohl M and  Lowe N and  Menter A and  Morison WL and  Prystowsky JH and  Shupack JL and  Taylor JR and  Weinstein GD and  Barton TL and  Rolstad T and  Day RM.},
  year = {2000},
  journal = {J Am Acad Dermatol},
  doi = {10.1067/mjd.2000.106374},
  url = {https://doi.org/10.1067/mjd.2000.106374}
}

RIS

TY  - JOUR
TI  - Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
AU  - Krueger GG
AU  -  Feldman SR
AU  -  Camisa C
AU  -  Duvic M
AU  -  Elder JT
AU  -  Gottlieb AB
AU  -  Koo J
AU  -  Krueger JG
AU  -  Lebwohl M
AU  -  Lowe N
AU  -  Menter A
AU  -  Morison WL
AU  -  Prystowsky JH
AU  -  Shupack JL
AU  -  Taylor JR
AU  -  Weinstein GD
AU  -  Barton TL
AU  -  Rolstad T
AU  -  Day RM.
PY  - 2000
JO  - J Am Acad Dermatol
DO  - 10.1067/mjd.2000.106374
UR  - https://doi.org/10.1067/mjd.2000.106374
ER  - 

APA

GG, K., SR, F., C, C., M, D., JT, E., AB, G., J, K., JG, K., M, L., N, L., A, M., WL, M., JH, P., JL, S., JR, T., GD, W., TL, B., T, R., & RM., D. (2000). Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?. J Am Acad Dermatol. https://doi.org/10.1067/mjd.2000.106374

Source records